In 2023, the sold production of human blood, animal blood prepared for therapeutic, prophylactic or diagnostic uses, cultures of micro-organisms, and toxins in Italy was estimated at a certain baseline value. From 2024 to 2028, the industry is forecasted to grow consistently, starting from 224.81 million Euros in 2024 and reaching 266.53 million Euros by 2028. This indicates a steady year-on-year increase with the compound annual growth rate (CAGR) reflecting a stable upward trend over these five years.

Future trends to watch for:

Advancements in biotechnology that could enhance production efficiencies.
Regulatory changes affecting the therapeutic and diagnostic applications of these products.
Increased demand driven by advancements in personalized medicine and emerging healthcare needs.
Potential impact of geopolitical and economic factors on the industry.